These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29858240)

  • 21. Remission and low disease activity state prevent hospitalizations in systemic lupus erythematosus patients.
    Reátegui-Sokolova C; Rodríguez-Bellido Z; Gamboa-Cárdenas RV; Medina M; Zevallos F; Pimentel-Quiroz VR; Elera-Fitzcarrald C; Cucho-Venegas M; Pastor-Asurza CA; Perich-Campos R; Alarcón GS; Ugarte-Gil MF
    Lupus; 2019 Oct; 28(11):1344-1349. PubMed ID: 31551028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated with remission in patients with systemic lupus erythematosus: new insights into a desirable state.
    Romo-Tena J; la Garza RR; Bartnicki-Navarrete I; Alcocer-Varela J; Gómez-Martin D
    Clin Rheumatol; 2018 Nov; 37(11):3033-3042. PubMed ID: 30056524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How can we define low disease activity in systemic lupus erythematosus?
    Tselios K; Gladman DD; Urowitz MB
    Semin Arthritis Rheum; 2019 Jun; 48(6):1035-1040. PubMed ID: 30415943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lupus mesenteric vasculitis: clinical features and associated factors for the recurrence and prognosis of disease.
    Yuan S; Ye Y; Chen D; Qiu Q; Zhan Z; Lian F; Li H; Liang L; Xu H; Yang X
    Semin Arthritis Rheum; 2014 Jun; 43(6):759-66. PubMed ID: 24332116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of clinical manifestations, disease activity and organ damage in 996 Korean patients with systemic lupus erythematosus: comparison with other Asian populations.
    Joo YB; Bae SC
    Int J Rheum Dis; 2015 Feb; 18(2):117-28. PubMed ID: 25524656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era.
    Stone JH; Millward CL; Olson JL; Amend WJ; Criswell LA
    Arthritis Rheum; 1998 Apr; 41(4):678-86. PubMed ID: 9550477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disease activity patterns in a monocentric cohort of SLE patients: a seven-year follow-up study.
    Zen M; Bassi N; Nalotto L; Canova M; Bettio S; Gatto M; Ghirardello A; Iaccarino L; Punzi L; Doria A
    Clin Exp Rheumatol; 2012; 30(6):856-63. PubMed ID: 22765883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of clinical predictors of flare in systemic lupus erythematosus patients: a 24-month prospective cohort study.
    Inês L; Duarte C; Silva RS; Teixeira AS; Fonseca FP; da Silva JA
    Rheumatology (Oxford); 2014 Jan; 53(1):85-9. PubMed ID: 24067885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrospective analysis of nephritis response and renal outcome in a cohort of 928 Egyptian lupus nephritis patients: a university hospital experience.
    Momtaz M; Fayed A; Wadie M; Gamal SM; Ghoniem SA; Sobhy N; Kamal Elden NM; Hamza WM
    Lupus; 2017 Dec; 26(14):1564-1570. PubMed ID: 28625079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) enables accurate and user-friendly definitions of clinical remission and categories of disease activity.
    Jesus D; Larosa M; Henriques C; Matos A; Zen M; Tomé P; Alves V; Costa N; Le Guern V; Iaccarino L; Costedoat-Chalumeau N; Doria A; Inês LS
    Ann Rheum Dis; 2021 Dec; 80(12):1568-1574. PubMed ID: 34407927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of anti-CD20 antibody rituximab for patients with refractory systemic lupus erythematosus.
    Iwata S; Saito K; Hirata S; Ohkubo N; Nakayamada S; Nakano K; Hanami K; Kubo S; Miyagawa I; Yoshikawa M; Miyazaki Y; Yoshinari H; Tanaka Y
    Lupus; 2018 Apr; 27(5):802-811. PubMed ID: 29308726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE.
    Dooley MA; Houssiau F; Aranow C; D'Cruz DP; Askanase A; Roth DA; Zhong ZJ; Cooper S; Freimuth WW; Ginzler EM;
    Lupus; 2013 Jan; 22(1):63-72. PubMed ID: 23263865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus.
    Tsang-A-Sjoe MW; Bultink IE; Heslinga M; Voskuyl AE
    Rheumatology (Oxford); 2017 Jan; 56(1):121-128. PubMed ID: 27803306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Belimumab on Flare Rate and Expected Damage Progression in Patients With Active Systemic Lupus Erythematosus.
    Iaccarino L; Bettio S; Reggia R; Zen M; Frassi M; Andreoli L; Gatto M; Piantoni S; Nalotto L; Franceschini F; Larosa M; Fredi M; Punzi L; Tincani A; Doria A
    Arthritis Care Res (Hoboken); 2017 Jan; 69(1):115-123. PubMed ID: 27390293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical profile and direct medical cost of care of adults presenting with systemic lupus erythematosus in Italy.
    Doria A; Iaccarino L; La Montagna G; Mathieu A; Piga M; Galeazzi M; Iuliano A; Maurel FB; Garofano AM; Perna AG; Porcasi RE
    Clin Exp Rheumatol; 2015; 33(3):375-84. PubMed ID: 26005879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequencies and predictors of the Lupus Low Disease Activity State and remission in treatment-naïve patients with systemic lupus erythematosus.
    Gao D; Hao Y; Mu L; Xie W; Fan Y; Ji L; Zhang Z
    Rheumatology (Oxford); 2020 Nov; 59(11):3400-3407. PubMed ID: 32337549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged remission in Caucasian patients with SLE: prevalence and outcomes.
    Zen M; Iaccarino L; Gatto M; Bettio S; Nalotto L; Ghirardello A; Punzi L; Doria A
    Ann Rheum Dis; 2015 Dec; 74(12):2117-22. PubMed ID: 26223434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained remission of lupus nephritis.
    Barber CE; Geldenhuys L; Hanly JG
    Lupus; 2006; 15(2):94-101. PubMed ID: 16539280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics of systemic lupus erythematosus patients in long-term remission without treatment.
    Jakez-Ocampo J; Rodriguez-Armida M; Fragoso-Loyo H; Lima G; Llorente L; Atisha-Fregoso Y
    Clin Rheumatol; 2020 Nov; 39(11):3365-3371. PubMed ID: 32870418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinically active serologically quiescent systemic lupus erythematosus.
    Gladman DD; Hirani N; Ibañez D; Urowitz MB
    J Rheumatol; 2003 Sep; 30(9):1960-2. PubMed ID: 12966598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.